• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

女性对透皮避孕的满意度和依从性高:一项来自欧洲多国、为期 6 个月的研究结果。

High levels of women's satisfaction and compliance with transdermal contraception: results from a European multinational, 6-month study.

机构信息

Center for Reproductive Health, Institute of Mother and Child, Warsaw, Poland.

出版信息

Gynecol Endocrinol. 2011 Oct;27(10):849-56. doi: 10.3109/09513590.2010.538095. Epub 2010 Dec 10.

DOI:10.3109/09513590.2010.538095
PMID:21142776
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3205821/
Abstract

OBJECTIVE

To investigate compliance, satisfaction, and preference in women using a transdermal contraceptive patch.

METHODS

Women (18-46 years) from eight European countries used contraceptive patches (norelgestromin 6 mg, ethinylestradiol 600 μg) for six, 4-week treatment cycles. Compliance, satisfaction, and preference were assessed after 3 and 6 cycles and study completion using self-report methods.

RESULTS

Of the 778 participants, 36.8% (n = 287) used no contraception at baseline. The most common methods were oral contraceptives (67.9%, n = 334) and barrier methods (21.5%, n = 106). Of oral contraception users, 63.5% (n = 212) were satisfied or very satisfied with their previous method, but compliance was poor with 77.8% (n = 260) reporting missed doses. After 3 and 6 cycles, >80% of all included women were satisfied or very satisfied with the patch. At study completion, most participants (73.7%) reported a preference for the patch compared to their previous method. Of 4107 cycles, 3718 (90.5%) were completed with perfect compliance. Two pregnancies occurred during this study, representing a Pearl Index of 0.63. No new safety issues were identified and the patch was well tolerated.

CONCLUSION

Women were highly satisfied with transdermal contraception and preferred this form of family planning over their previous method. Transdermal contraception represents a valuable addition to contraceptive options with potential to offer high compliance and efficacy.

摘要

目的

调查使用透皮避孕贴的女性的依从性、满意度和偏好。

方法

来自 8 个欧洲国家的女性(18-46 岁)使用避孕贴(炔诺孕酮 6mg,炔雌醇 600μg)进行了 6 个 4 周的治疗周期。使用自我报告的方法在第 3 和第 6 个周期以及研究结束后评估依从性、满意度和偏好。

结果

在 778 名参与者中,36.8%(n=287)在基线时没有使用任何避孕方法。最常见的方法是口服避孕药(67.9%,n=334)和屏障法(21.5%,n=106)。在口服避孕药使用者中,63.5%(n=212)对其之前的方法感到满意或非常满意,但依从性很差,77.8%(n=260)报告漏服。在第 3 和第 6 个周期后,超过 80%的所有纳入女性对贴片感到满意或非常满意。在研究结束时,大多数参与者(73.7%)表示更喜欢贴片而不是之前的方法。在 4107 个周期中,有 3718 个(90.5%)周期完全符合依从性要求。在这项研究期间发生了两例妊娠,妊娠率为 0.63。没有发现新的安全问题,贴片耐受良好。

结论

女性对透皮避孕非常满意,并且更喜欢这种形式的计划生育方法而不是之前的方法。透皮避孕是一种有价值的避孕方法选择,具有提供高依从性和疗效的潜力。

相似文献

1
High levels of women's satisfaction and compliance with transdermal contraception: results from a European multinational, 6-month study.女性对透皮避孕的满意度和依从性高:一项来自欧洲多国、为期 6 个月的研究结果。
Gynecol Endocrinol. 2011 Oct;27(10):849-56. doi: 10.3109/09513590.2010.538095. Epub 2010 Dec 10.
2
Satisfaction and compliance in hormonal contraception: the result of a multicentre clinical study on women's experience with the ethinylestradiol/norelgestromin contraceptive patch in Italy.激素避孕的满意度与依从性:意大利一项关于女性使用炔雌醇/去氧孕烯避孕贴片体验的多中心临床研究结果
BMC Womens Health. 2009 Jun 30;9:18. doi: 10.1186/1472-6874-9-18.
3
Preference for and satisfaction of Canadian women with the transdermal contraceptive patch versus previous contraceptive method: an open-label, multicentre study.加拿大女性对经皮避孕贴片与先前避孕方法的偏好及满意度:一项开放标签、多中心研究。
J Obstet Gynaecol Can. 2005 Apr;27(4):350-9. doi: 10.1016/s1701-2163(16)30462-5.
4
Transdermal ethinylestradiol/norelgestromin: a review of its use in hormonal contraception.经皮炔雌醇/去氧孕烯炔雌醇:其在激素避孕中的应用综述
Treat Endocrinol. 2003;2(3):191-206. doi: 10.2165/00024677-200302030-00005.
5
Adolescents' experiences using the contraceptive patch versus pills.青少年使用避孕贴片与避孕药丸的经历。
J Pediatr Adolesc Gynecol. 2011 Aug;24(4):197-203. doi: 10.1016/j.jpag.2011.02.001. Epub 2011 Mar 30.
6
Transdermal hormonal contraception: benefits and risks.经皮激素避孕:益处与风险。
Am J Obstet Gynecol. 2007 Aug;197(2):134.e1-6. doi: 10.1016/j.ajog.2007.04.027.
7
A clinical study of transdermal contraceptive patch in Thai adolescence women.泰国青春期女性使用经皮避孕贴片的临床研究。
J Med Assoc Thai. 2008 Feb;91(2):137-41.
8
Evaluation of the contraceptive efficacy, compliance, and satisfaction with the transdermal contraceptive patch system Evra: a comparison between adolescent and adult users.评价透皮避孕贴片系统依维乐的避孕效果、依从性和满意度:青少年使用者和成年使用者之间的比较。
Arch Gynecol Obstet. 2011 Mar;283(3):525-30. doi: 10.1007/s00404-010-1368-6. Epub 2010 Jan 29.
9
New Product Review (September 2003). Norelgestromin/ethinyl oestradiol transdermal contraceptive system (Evra).新产品评论(2003年9月)。诺孕酯/炔雌醇经皮避孕系统(依伴依)
J Fam Plann Reprod Health Care. 2004 Jan;30(1):43-5. doi: 10.1783/147118904322701974.
10
Ethinylestradiol + norelgestromin: new preparation. Transdermal contraception: no tangible progress.炔雌醇 + 诺孕酯:新制剂。经皮避孕:无显著进展。
Prescrire Int. 2004 Aug;13(72):123-6.

引用本文的文献

1
Non-daily contraception: Reinforcing the choice of users and addressing unmet needs of reproductive health.非每日使用的避孕方法:强化使用者的选择并满足生殖健康方面未被满足的需求。
Acta Obstet Gynecol Scand. 2025 Feb;104(2):253-257. doi: 10.1111/aogs.15014. Epub 2024 Dec 20.
2
Extended regimen of a levonorgestrel/ethinyl estradiol transdermal delivery system: Predicted serum hormone levels using a population pharmacokinetic model.左炔诺孕酮/炔雌醇透皮贴剂的延长治疗方案:应用群体药代动力学模型预测血清激素水平。
PLoS One. 2022 Dec 27;17(12):e0279640. doi: 10.1371/journal.pone.0279640. eCollection 2022.
3
Transdermal delivery of combined hormonal contraception: a review of the current literature.

本文引用的文献

1
Extended case-control study results on thromboembolic outcomes among transdermal contraceptive users.关于经皮避孕药使用者血栓栓塞结局的扩展病例对照研究结果。
Contraception. 2010 May;81(5):408-13. doi: 10.1016/j.contraception.2009.12.009. Epub 2010 Jan 22.
2
Postmarketing study of ORTHO EVRA and levonorgestrel oral contraceptives containing hormonal contraceptives with 30 mcg of ethinyl estradiol in relation to nonfatal venous thromboembolism.含 30 微克炔雌醇的左炔诺孕酮与依托孕烯皮下埋植剂和含 30 微克炔雌醇的左炔诺孕酮口服避孕药的上市后研究与非致死性静脉血栓栓塞症相关。
Contraception. 2010 Jan;81(1):16-21. doi: 10.1016/j.contraception.2009.07.004.
3
复方激素避孕的经皮给药:当前文献综述
Int J Womens Health. 2017 May 15;9:315-321. doi: 10.2147/IJWH.S102306. eCollection 2017.
4
Effect of a low-dose contraceptive patch on efficacy, bleeding pattern, and safety: a 1-year, multicenter, open-label, uncontrolled study.低剂量避孕贴对疗效、出血模式和安全性的影响:一项为期 1 年、多中心、开放标签、非对照研究。
Reprod Sci. 2014 Dec;21(12):1518-25. doi: 10.1177/1933719114532840. Epub 2014 Apr 30.
5
International survey to assess women's attitudes regarding choice of daily versus nondaily female hormonal contraception.评估女性对日常与非日常女性激素避孕选择的态度的国际调查。
Int J Womens Health. 2014 Apr 3;6:367-75. doi: 10.2147/IJWH.S59059. eCollection 2014.
6
Transdermal therapy for attention-deficit hyperactivity disorder with the methylphenidate patch (MTS).经皮治疗注意缺陷多动障碍的哌醋甲酯贴片(MTS)。
CNS Drugs. 2014 Mar;28(3):217-28. doi: 10.1007/s40263-014-0141-y.
7
Evaluation of factors associated with noncompliance in users of combined hormonal contraceptive methods: a cross-sectional study: results from the MIA study.评估与联合激素避孕方法使用者不依从相关的因素:一项横断面研究:来自 MIA 研究的结果。
BMC Womens Health. 2013 Oct 20;13:38. doi: 10.1186/1472-6874-13-38.
Safety, efficacy and patient acceptability of the combined estrogen and progestin transdermal contraceptive patch: a review.
雌激素与孕激素联合透皮避孕贴片的安全性、有效性及患者可接受性:综述
Patient Prefer Adherence. 2008 Feb 2;2:357-67. doi: 10.2147/ppa.s3233.
4
Satisfaction and compliance in hormonal contraception: the result of a multicentre clinical study on women's experience with the ethinylestradiol/norelgestromin contraceptive patch in Italy.激素避孕的满意度与依从性:意大利一项关于女性使用炔雌醇/去氧孕烯避孕贴片体验的多中心临床研究结果
BMC Womens Health. 2009 Jun 30;9:18. doi: 10.1186/1472-6874-9-18.
5
Eligibility criteria in venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users.经皮避孕系统使用者中静脉血栓栓塞、心肌梗死和中风的入选标准。
Obstet Gynecol. 2009 Jul;114(1):175. doi: 10.1097/AOG.0b013e3181aa92ee.
6
Skin patch and vaginal ring versus combined oral contraceptives for contraception.皮肤贴片和阴道环与复方口服避孕药用于避孕的比较。
Cochrane Database Syst Rev. 2008 Jan 23(1):CD003552. doi: 10.1002/14651858.CD003552.pub2.
7
Transdermal hormonal contraception: benefits and risks.经皮激素避孕:益处与风险。
Am J Obstet Gynecol. 2007 Aug;197(2):134.e1-6. doi: 10.1016/j.ajog.2007.04.027.
8
Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.与使用含诺孕酯和35微克炔雌醇的口服避孕药的使用者相比,避孕透皮贴剂使用者发生非致命性静脉血栓栓塞风险的进一步研究结果。
Contraception. 2007 Jul;76(1):4-7. doi: 10.1016/j.contraception.2007.03.003. Epub 2007 May 11.
9
Treatment satisfaction with a transdermal contraceptive patch or oral contraceptives.经皮避孕贴片或口服避孕药的治疗满意度。
Contraception. 2007 Apr;75(4):281-4. doi: 10.1016/j.contraception.2006.12.003. Epub 2007 Feb 16.
10
Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users.经皮避孕系统使用者中的静脉血栓栓塞、心肌梗死和中风。
Obstet Gynecol. 2007 Feb;109(2 Pt 1):339-46. doi: 10.1097/01.AOG.0000250968.82370.04.